Preferences of pregnant women and obstetric healthcare professionals on using noninvasive prenatal testing to predict adverse pregnancy outcomes: a discrete choice experiment

被引:0
|
作者
Becking, Ellis [1 ]
Akkerman, Elisabeth [2 ]
Scheffer, Peter [2 ]
Smith, Ian [3 ]
Stemkens, Daphne [4 ]
Bax, Caroline J. [5 ,6 ]
Bekker, Mireille N. [2 ]
Crombag, Neeltje [7 ]
Schuit, Ewoud [8 ]
Henneman, Lidewij [9 ]
机构
[1] Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[2] Univ Utrecht, Dept Obstet, Utrecht, Netherlands
[3] Univ Utrecht, Utrecht, Netherlands
[4] VSOP, Soest, Netherlands
[5] Univ Amsterdam, Dept Obstet, Amsterdam, Netherlands
[6] Amsterdam Reprod & Dev Res Inst, Amsterdam, Netherlands
[7] Univ Med Ctr Utrecht, Utrecht, Netherlands
[8] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[9] Amsterdam UMC Locatie AMC, Amsterdam, Netherlands
来源
BMJ OPEN | 2025年 / 15卷 / 01期
关键词
Pregnancy; OBSTETRICS; GYNAECOLOGY; CELL-FREE DNA; DOWN-SYNDROME; PREECLAMPSIA; NIPT;
D O I
10.1136/bmjopen-2024-088304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Noninvasive prenatal testing (NIPT) to screen for fetal aneuploidies by analysing cell-free DNA in maternal plasma is available to pregnant women worldwide. In the future, the scope of NIPT could potentially be expanded to the prediction of adverse pregnancy outcomes. The objective of this study was to assess and compare the preferences of pregnant women and obstetric healthcare professionals on this new test purpose of NIPT. Design A discrete choice experiment was designed to assess participants' preferences on the use of NIPT to predict adverse pregnancy outcomes regarding three attributes on test characteristics: test accuracy rate, unnecessary intervention rate and false reassurance rate. A questionnaire assessed general attitudes towards using noninvasive prenatal testing to predict adverse pregnancy outcomes. Setting Dutch prenatal healthcare system. Participants Pregnant women with singleton pregnancies and obstetric healthcare professionals. Results In total, 1580 pregnant women and 308 obstetric healthcare professionals participated in the discrete choice experiment. Higher test accuracy, fewer unnecessary interventions and less false reassurance all had a statistically significant (p<0.05) impact on the preference for a test. For pregnant women, the most important test characteristic when choosing a preferred test was the test accuracy rate, while for obstetric healthcare professionals, the most important test characteristic was the unnecessary intervention rate. The false reassurance rate was the least important test characteristic for both groups. Overall, 74% (n=1181) of pregnant women (strongly) agreed that NIPT to predict adverse pregnancy outcomes should be offered to pregnant women compared with 49% (n=151) of obstetric healthcare professionals. Conclusions Most pregnant women have a positive attitude towards using NIPT to predict adverse pregnancy outcomes compared with slightly less than half of the obstetric healthcare professionals. Pregnant women prioritise a prognostic test with higher test accuracy, while obstetric healthcare professionals prioritise a test that results in fewer unnecessary interventions.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Measuring High-Risk Patients' Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment
    Dong, Di
    Ozdemir, Semra
    Bee, Yong Mong
    Toh, Sue-Anne
    Bilger, Marcel
    Finkelstein, Eric
    VALUE IN HEALTH, 2016, 19 (06) : 767 - 775
  • [42] Can Inflammatory Indices be Used to Predict Adverse Pregnancy Outcomes in Pregnant Women with Recurrent Urinary Tract Infection?
    Keles, Ayse
    Dagdeviren, Gulsah
    Yucel Celik, Ozge
    Ozturk, Azize Cemre
    Obut, Mehmet
    Celen, Sevki
    Calar, Ali Turhan
    DUZCE MEDICAL JOURNAL, 2022, 24 (03) : 215 - 220
  • [43] Assessing women's preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design
    Hammond, Jennifer
    Klapwijk, Jasmijn E.
    Riedijk, Sam
    Lou, Stina
    Ormond, Kelly E.
    Vogel, Ida
    Hui, Lisa
    Sziepe, Emma-Jane
    Buchanan, James
    Ingvoldstad-Malmgren, Charlotta
    Soller, Maria Johansson
    Harding, Eleanor
    Hill, Melissa
    Lewis, Celine
    PLOS ONE, 2022, 17 (01):
  • [44] The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access
    Birko, Stanislav
    Ravitsky, Vardit
    Dupras, Charles
    Le Clerc-Blain, Jessica
    Lemoine, Marie-Eve
    Affdal, Aliya O.
    Haidar, Hazar
    Laberge, Anne-Marie
    BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (1)
  • [45] The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access
    Stanislav Birko
    Vardit Ravitsky
    Charles Dupras
    Jessica Le Clerc-Blain
    Marie-Eve Lemoine
    Aliya O. Affdal
    Hazar Haidar
    Anne-Marie Laberge
    BMC Pregnancy and Childbirth, 19
  • [46] Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)
    Najafzadeh, Mehdi
    Johnston, Karissa M.
    Peacock, Stuart J.
    Connors, Joseph M.
    Marra, Marco A.
    Lynd, Larry D.
    Marra, Carlo A.
    BMC HEALTH SERVICES RESEARCH, 2013, 13
  • [47] What matters when managing childhood fever in the emergency department? A discrete-choice experiment comparing the preferences of parents and healthcare professionals in the UK
    Leigh, Simon
    Robinson, Jude
    Yeung, Shunmay
    Coenen, Frans
    Carrol, Enitan D.
    Niessen, Louis W.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (08) : 765 - 771
  • [48] Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)
    Mehdi Najafzadeh
    Karissa M Johnston
    Stuart J Peacock
    Joseph M Connors
    Marco A Marra
    Larry D Lynd
    Carlo A Marra
    BMC Health Services Research, 13
  • [49] Estimating the Danish Populations' Preferences for Pharmacogenetic Testing Using a Discrete Choice Experiment. The Case of Treating Depression
    Herbild, Louise
    Bech, Mickael
    Gyrd-Hansen, Dorte
    VALUE IN HEALTH, 2009, 12 (04) : 560 - 567
  • [50] Exploring women's preferences for HPV-based cervical cancer screening using a discrete choice experiment
    Oberlin, A.
    Pasipamire, T.
    Chibwesha, C. J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 219 (06) : 635 - 636